Kintara Therapeutics Inc (NASDAQ:KTRA) does about 11.39M shares in volume on a normal day but saw 3756344 shares change hands in the recent trading day. The company now has a market cap of 9.97M USD. Its current market price is $0.18, marking a decrease of -18.20% compared to the previous close of $0.22. The 52 week high reached by this stock is $5.00 whilst the lowest price level in 52 weeks is $0.08.
Kintara Therapeutics Inc (KTRA) has a 20-day trading average at $0.2494 and the current price is -96.40% off the 52-week high compared with 122.47% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2448 and its 200-day simple moving average is $0.3900. If we look at the stock’s price movements over the week, volatility stands at 11.06%, which increases to 11.27% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 35.00 to suggest the stock is neutral.
The consensus objective for the share price is $14.00, suggesting that the stock has a potential upside of 98.71% over the period.
4 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
Kintara Therapeutics Inc (KTRA) stock is down -26.39% over the week and -34.83% over the past month. Its price is 6.25% year-to-date and -95.69% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/30/2023, with the company’s earnings per share (EPS) of -3.5 below consensus estimates by -3.5. The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 98.71 percent from here.
The company has a return on investment of -160.62% and return on equity of -192.23%. The beta has a value of 0.81.
